Print This Page

The following are the five Clinical Proteomic Tumor Analysis Consortium (CPTAC) teams, representing a network of eight Proteome Characterization Centers.  Teams are listed by grant title with their respective Principal Investigators:

Cancer Proteomic Center at Washington University, University of North Carolina and Boise State University

• Washington University, St. Louis, MO
  Principal Investigators: Matthew J. C. Ellis, M.B., Ph.D.; R. Reid Townsend, M.D., Ph.D.
• University of North Carolina, Chapel Hill, NC
  Principal Investigator: Xian Chen, Ph.D.
• Boise State University, Boise, ID
  Principal Investigator: Morgan C. Giddings, Ph.D.

Center for Application of Advanced Clinical Proteomic Technologies for Cancer

• Pacific Northwest National Laboratory, Richland, WA
  Principal Investigators: Richard D. Smith, Ph.D.; Karin D. Rodland, Ph.D.

Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers

• Johns Hopkins University, Baltimore, MD
  Principal Investigators: Daniel W. Chan, Ph.D.; Hui Zhang, Ph.D.; Zhen Zhang, Ph.D.

Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers

• The Broad Institute, Cambridge, MA
  Principal Investigator: Steven A. Carr, Ph.D.
• Fred Hutchinson Cancer Research Center, Seattle, WA
  Principal Investigator: Amanda G. Paulovich M.D., Ph.D.

Vanderbilt Proteome Characterization Center

• Vanderbilt University, Nashville, TN
  Principal Investigator: Daniel C.Liebler, Ph.D.